Literature DB >> 32243307

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins1, Richard S Guido2, Philip E Castle3, David Chelmow4, Mark H Einstein5, Francisco Garcia6, Warner K Huh7, Jane J Kim8, Anna-Barbara Moscicki9, Ritu Nayar10, Mona Saraiya11, George F Sawaya12, Nicolas Wentzensen13, Mark Schiffman13.   

Abstract

Entities:  

Year:  2020        PMID： 32243307      PMCID： PMC7147428          DOI： 10.1097/LGT.0000000000000525

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN： 1089-2591            Impact factor:   1.925


× No keyword cloud information.
  112 in total

1.  The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.

Authors:  Furong Yu; Jie Liu; Weilei Dong; Jing Xie; Xia Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 2.  Screening for Cervical Cancer.

Authors:  Terresa J Eun; Rebecca B Perkins
Journal:  Med Clin North Am       Date:  2020-11       Impact factor: 5.456

3.  Negative loop electrosurgical excision procedure (LEEP) following cervical biopsy diagnosis of high grade squamous intraepithelial lesion.

Authors:  Fatima Zahra Aly; Alyaa Irhayyim; Jacquelyn Knapik; Robert Klein
Journal:  Int J Clin Exp Pathol       Date:  2021-12-15

4.  Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population.

Authors:  Jaimie Z Shing; Marie R Griffin; Rachel S Chang; Alicia Beeghly-Fadiel; Staci L Sudenga; James C Slaughter; Manideepthi Pemmaraju; Edward F Mitchel; Pamela C Hull
Journal:  Am J Prev Med       Date:  2021-10-29       Impact factor: 5.043

5.  Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.

Authors:  Mona Saraiya; Li C Cheung; Ashwini Soman; Jacqueline Mix; Kristy Kenney; Xiaojian Chen; Rebecca B Perkins; Mark Schiffman; Nicolas Wentzensen; Jacqueline Miller
Journal:  Am J Obstet Gynecol       Date:  2020-10-06       Impact factor: 8.661

6.  Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020.

Authors:  Rebecca B Perkins; Richard L Guido; Mona Saraiya; George F Sawaya; Nicolas Wentzensen; Mark Schiffman; Sarah Feldman
Journal:  J Womens Health (Larchmt)       Date:  2021-01       Impact factor: 2.681

7.  The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening.

Authors:  Mark Schiffman; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

8.  Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.

Authors:  Hillary Hosier; Sangini S Sheth; Carlos R Oliveira; Lauren E Perley; Alla Vash-Margita
Journal:  Am J Obstet Gynecol       Date:  2021-07-10       Impact factor: 8.661

9.  Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.

Authors:  Huifeng Xue; Hangjing Gao; Jinwen Zheng; Yaojia Chen; Jiancui Chen; Diling Pan; Binhua Dong; Pengming Sun
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.

Authors:  Yanxia Zhao; Heling Bao; Lan Ma; Bo Song; Jiangli Di; Linhong Wang; Yanqiu Gao; Wenhui Ren; Shi Wang; Hai-Jun Wang; Jiuling Wu
Journal:  BMC Med       Date:  2021-07-15       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.